Comprehensive review of natural products targeting lapatinib resistance-related pathways in breast cancer as future strategies to overcome lapatinib resistance
Phytomedicine · 2026-10 · 160 · 158698
DOI: 10.1016/j.phymed.2026.158698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytomedicine, 2026-10. Verfasst von I Made Bayu Kresna Yoga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, Yogya…. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Lapatinib, Biological Products. Die Arbeit nennt 347 Literaturangaben. Gefördert von: Universitas Gadjah Mada.
Abstract (Originalsprache)
BACKGROUND: Lapatinib (LAP) significantly improves outcomes in HER2-positive (HER2+) breast cancer, including trastuzumab-resistant p95HER2-expressing tumors. However, primary and acquired resistance remain unmet clinical challenges. Multiple studies have highlighted the promising role of natural products in breast cancer therapy. Given their ability to modulate multiple oncogenic signaling pathways, these compounds also represent potential therapeutic agents for overcoming LAP resistance. PURPOSE: In this review, we integrate current evidence on the molecular mechanisms underlying LAP resistance with the therapeutic potential of natural products to overcome these resistance pathways. STUDY DESIGN: We analyzed studies published between 2006 and 2026 investigating natural products in breast cancer, with a particular focus on their modulation of LAP resistance-associated molecular networks. RESULTS: A total of 194 preclinical studies and 34 clinical trial reports were included. Apoptosis (n = 64) and PI3K/AKT/mTOR signaling (n = 59) were the most frequently targeted mechanisms, followed by RAS/RAF/MEK/MAPK (n = 32), autophagy (n = 17), cell plasticity (n = 13), HER and FOXO signaling (n = 11 each), with fewer studies targeting Src, MET, IGF-1R, FGFR, PTEN, PP2A, and BRK pathways. CONCLUSION: This review highlights the potential of natural products to target the complex molecular networks underlying LAP resistance, although further validation in LAP-resistant models and dedicated clinical trials is required to confirm their therapeutic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, Yogyakarta, 55281, Indonesia; Department of Pharmaceutical Chemistry, Facul…
- Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, Yogyakarta, 55281, Indonesia.
- Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia.
- Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, Yogyakarta, 55281, Indonesia. Electronic address: adam_apt@ugm.ac.id.
Förderung
- Universitas Gadjah Mada
Zitieren
APA
Yoga, I. M. B. K., Irmasari, I., Widyardhita, M. H., Maharani, D., Widayanti, W. R., Amalia, A., Ningsih, S. R., Saputra, B. W., Haidar, I., Putri, D. D. P., & Hermawan, A. (2026). Comprehensive review of natural products targeting lapatinib resistance-related pathways in breast cancer as future strategies to overcome lapatinib resistance. Phytomedicine, 160, 158698. https://doi.org/10.1016/j.phymed.2026.158698
Vancouver
Yoga IMBK, Irmasari I, Widyardhita MH, Maharani D, Widayanti WR, Amalia A, et al. Comprehensive review of natural products targeting lapatinib resistance-related pathways in breast cancer as future strategies to overcome lapatinib resistance. Phytomedicine. 2026;160:158698. doi:10.1016/j.phymed.2026.158698
BibTeX
@article{Yoga2026,
author = {Yoga, I Made Bayu Kresna and Irmasari, Irmasari and Widyardhita, Monica Hana and Maharani, Dini and Widayanti, Wasita Rachma and Amalia, Amalia and Ningsih, Sri Rahmayani and Saputra, Bakti Wahyu and Haidar, Inas and Putri, Dyaningtyas Dewi Pamungkas and Hermawan, Adam},
title = {Comprehensive review of natural products targeting lapatinib resistance-related pathways in breast cancer as future strategies to overcome lapatinib resistance},
journal = {Phytomedicine},
year = {2026},
volume = {160},
pages = {158698},
doi = {10.1016/j.phymed.2026.158698}
}
EUVIMED